Advertisement
Loading...

Illumina, Inc.

ILMNNASDAQ
Healthcare
Medical - Diagnostics & Research
$142.54
$-0.70(-0.49%)
U.S. Market opens in 37h 54m

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap21.6B
P/E Ratio25.46
EPS (TTM)$5.50
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$116.35
3 Months$80.27
1 Year Target$89.80

ILMN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Illumina, Inc. (ILMN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.30, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $89.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.46 and a market capitalization of 21.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.49%
5-Day Change
3.29%
1-Month Change
7.77%
3-Month Change
22.03%
6-Month Change
18.12%
Year-to-Date (YTD) Change
8.68%
1-Year Change
76.19%
3-Year Change
-28.40%
5-Year Change
-61.35%
All-Time (Max) Change
649.03%

Contact Information

858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

8,970 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions